Epoetin alfa

Epoetin alfa

Identifiers
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}

WikiDoc Resources for Epoetin alfa
Articles
Most recent articles on Epoetin alfa Most cited articles on Epoetin alfa Review articles on Epoetin alfa Articles on Epoetin alfa in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Epoetin alfa Images of Epoetin alfa Photos of Epoetin alfa Podcasts & MP3s on Epoetin alfa Videos on Epoetin alfa
Evidence Based Medicine
Cochrane Collaboration on Epoetin alfa Bandolier on Epoetin alfa TRIP on Epoetin alfa
Clinical Trials
Ongoing Trials on Epoetin alfa at Clinical Trials.gov Trial results on Epoetin alfa Clinical Trials on Epoetin alfa at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Epoetin alfa NICE Guidance on Epoetin alfa NHS PRODIGY Guidance FDA on Epoetin alfa CDC on Epoetin alfa
Books
Books on Epoetin alfa
News
Epoetin alfa in the news Be alerted to news on Epoetin alfa News trends on Epoetin alfa
Commentary
Blogs on Epoetin alfa
Definitions
Definitions of Epoetin alfa
Patient Resources / Community
Patient resources on Epoetin alfa Discussion groups on Epoetin alfa Patient Handouts on Epoetin alfa Directions to Hospitals Treating Epoetin alfa Risk calculators and risk factors for Epoetin alfa
Healthcare Provider Resources
Symptoms of Epoetin alfa Causes & Risk Factors for Epoetin alfa Diagnostic studies for Epoetin alfa Treatment of Epoetin alfa
Continuing Medical Education (CME)
CME Programs on Epoetin alfa
International
Epoetin alfa en Espanol Epoetin alfa en Francais
Business
Epoetin alfa in the Marketplace Patents on Epoetin alfa
Experimental / Informatics
List of terms related to Epoetin alfa

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Epoetin alfa (rINN) (Template:PronEng) is a synthetic form of erythropoietin. It stimulates erythropoiesis (increases red blood cell levels) and is used to treat anemia, commonly associated with chronic renal failure and cancer chemotherapy. Epoetin is marketed under the trade names Procrit and Epogen.

See also

• Erythropoietin

External links

• FDA hearing on erythropoiesis-stimulating agents - fda.gov.

References

Template:SIB Template:WH Template:WikiDoc Sources